Target intelligence / Profile preview

RNA, U6 small nuclear 621, pseudogene (RNU6-621P)

Target
RNU6-621P
Molecular classification
Other
01

Overview

RNA, U6 small nuclear 621, pseudogene (RNU6-621P) is classified as a **pseudogene** of U6 small nuclear RNA (snRNA), meaning it is a non-coding genomic sequence resembling a functional U6 snRNA gene but generally considered non-functional. U6 snRNA is an essential RNA component of the spliceosome required for pre-mRNA splicing in eukaryotes[1][3]. However, pseudogenes such as RNU6-621P typically do not produce functional RNA or protein products and are not involved in cellular processes, disease roles, or therapeutic drug targeting. Their biological significance, if any, is usually regulatory or non-coding RNA-related; currently, there is no evidence that RNU6-621P has a direct biological or clinical function[4]. \n\n**Notes:**\n- RNU6-621P is not a receptor, enzyme, transporter, or any classical \"therapeutic target.\"\n- Its designation as a pseudogene means it is not usually expressed as a functional molecule, and there are no known drugs or biomarkers associated with it.\n- There is nothing to indicate this pseudogene is formally implicated in disease or therapeutic intervention.\n\nReferences: RNU6-621P basic info[4]; U6 snRNA biological context[1][3]; pseudogene functions[2].

Other names
RNU6-621P

Beyond the preview

Go deeper on RNA, U6 small nuclear 621, pseudogene (RNU6-621P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 621, pseudogene (RNU6-621P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call